Publications

Havervall S, Ng H, Jernbom Falk A, Greilert-Norin N, Månberg A, Marking U,
Laurén I, Gabrielsson L, Salomonsson AC, Aguilera K, Kihlgren M, Månsson M,
Rosell A, Hellström C, Andersson E, Olofsson J, Skoglund L, Yousef J, Pin E,
Lord M, Åberg M, Hedhammar M, Tegel H, Dönnes P, Phillipson M, Nilsson P,
Klingström J, Mangsbo S, Hober S, Thålin C. Robust humoral and cellular immune
responses and low risk for reinfection at least 8 months following asymptomatic
to mild COVID-19. J Intern Med. 2022 Jan;291(1):72-80. doi: 10.1111/joim.13387.
Epub 2021 Sep 27. PMID: 34459525; PMCID: PMC8661920.

Assenhöj M, Eriksson P, Dönnes P, Ljunggren SA, Marcusson-Ståhl M, Du Rietz
A, Uvdal K, Karlsson H, Cederbrant K. Protein interaction, monocyte toxicity and
immunogenic properties of cerium oxide crystals with 5% or 14% gadolinium,
cobalt oxide and iron oxide nanoparticles – an interdisciplinary approach.
Nanotoxicology. 2021 Oct;15(8):1035-1058. doi: 10.1080/17435390.2021.1966115.
Epub 2021 Sep 1. PMID: 34468264.

Peng J, Jury EC, Dönnes P, Ciurtin C. Machine Learning Techniques for
Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory
Diseases: Applications and Challenges. Front Pharmacol. 2021 Sep 30;12:720694.
doi: 10.3389/fphar.2021.720694. PMID: 34658859; PMCID: PMC8514674.

Mangsbo SM, Havervall S, Laurén I, Lindsay R, Jernbom Falk A, Marking U, Lord
M, Buggert M, Dönnes P, Christoffersson G, Nilsson P, Hober S, Phillipson M,
Klingström J, Thålin C. An evaluation of a FluoroSpot assay as a diagnostic tool
to determine SARS-CoV-2 specific T cell responses. PLoS One. 2021 Sep
30;16(9):e0258041. doi: 10.1371/journal.pone.0258041. PMID: 34591918; PMCID:
PMC8483319.

Coelewij L, Waddington KE, Robinson GA, Chocano E, McDonnell T, Farinha F,
Peng J, Dönnes P, Smith E, Croca S, Bakshi J, Griffin M, Nicolaides A, Rahman A,
Jury EC, Pineda-Torra I. Serum Metabolomic Signatures Can Predict Subclinical
Atherosclerosis in Patients With Systemic Lupus Erythematosus. Arterioscler
Thromb Vasc Biol. 2021 Apr;41(4):1446-1458. doi: 10.1161/ATVBAHA.120.315321.
Epub 2021 Feb 4. PMID: 33535791; PMCID: PMC7610443.

Hässler S, Bachelet D, Duhaze J, Szely N, Gleizes A, Hacein-Bey Abina S,
Aktas O, Auer M, Avouac J, Birchler M, Bouhnik Y, Brocq O, Buck-Martin D, Cadiot
G, Carbonnel F, Chowers Y, Comabella M, Derfuss T, De Vries N, Donnellan N,
Doukani A, Guger M, Hartung HP, Kubala Havrdova E, Hemmer B, Huizinga T,
Ingenhoven K, Hyldgaard-Jensen PE, Jury EC, Khalil M, Kieseier B, Laurén A,
Lindberg R, Loercher A, Maggi E, Manson J, Mauri C, Mohand Oumoussa B, Montalban
X, Nachury M, Nytrova P, Richez C, Ryner M, Sellebjerg F, Sievers C, Sikkema D,
Soubrier M, Tourdot S, Trang C, Vultaggio A, Warnke C, Spindeldreher S, Dönnes
P, Hickling TP, Hincelin Mery A, Allez M, Deisenhammer F, Fogdell-Hahn A,
Mariette X, Pallardy M, Broët P; ABIRISK consortium. Clinicogenomic factors of
biotherapy immunogenicity in autoimmune disease: A prospective multicohort study
of the ABIRISK consortium. PLoS Med. 2020 Oct 30;17(10):e1003348. doi:
10.1371/journal.pmed.1003348. PMID: 33125391; PMCID: PMC7598520.

Robinson GA, Peng J, Dönnes P, Coelewij L, Naja M, Radziszewska A, Wincup C,
Peckham H, Isenberg DA, Ioannou Y, Pineda-Torra I, Ciurtin C, Jury EC. Disease-
associated and patient-specific immune cell signatures in juvenile-onset
systemic lupus erythematosus: patient stratification using a machine-learning
approach. Lancet Rheumatol. 2020 Jul 29;2(8):e485-e496. doi:
10.1016/S2665-9913(20)30168-5. PMID: 32818204; PMCID: PMC7425802.

Waddington KE, Papadaki A, Coelewij L, Adriani M, Nytrova P, Kubala Havrdova
E, Fogdell-Hahn A, Farrell R, Dönnes P, Pineda-Torra I, Jury EC. Using Serum
Metabolomics to Predict Development of Anti-drug Antibodies in Multiple
Sclerosis Patients Treated With IFNβ. Front Immunol. 2020 Jul 17;11:1527. doi:
10.3389/fimmu.2020.01527. PMID: 32765529; PMCID: PMC7380268.

Synnergren J, Vukusic K, Dönnes P, Jonsson M, Lindahl A, Dellgren G, Jeppsson
A, Asp J. Transcriptional sex and regional differences in paired human atrial
and ventricular cardiac biopsies collected in vivo. Physiol Genomics. 2020 Feb
1;52(2):110-120. doi: 10.1152/physiolgenomics.00036.2019. Epub 2019 Dec 23.
PMID: 31869284.

Bachelet D, Albert T, Mbogning C, Hässler S, Zhang Y, Schultze-Strasser S,
Repessé Y, Rayes J, Pavlova A, Pezeshkpoor B, Liphardt K, Davidson JE, Hincelin-
Méry A, Dönnes P, Lacroix-Desmazes S, Königs C, Oldenburg J, Broët P; ABIRISK
consortium. Risk stratification integrating genetic data for factor VIII
inhibitor development in patients with severe hemophilia A. PLoS One. 2019 Jun
13;14(6):e0218258. doi: 10.1371/journal.pone.0218258. PMID: 31194850; PMCID:
PMC6564000.

Quistrebert J, Hässler S, Bachelet D, Mbogning C, Musters A, Tak PP,
Wijbrandts CA, Herenius M, Bergstra SA, Akdemir G, Johannesson M, Combe B,
Fautrel B, Chollet-Martin S, Gleizes A, Donnellan N, Deisenhammer F, Davidson J,
Hincelin-Mery A, Dönnes P, Fogdell-Hahn A, De Vries N, Huizinga T, Abugessaisa
I, Saevarsdottir S, Hacein-Bey-Abina S, Pallardy M, Broët P, Mariette X; ABIRISK
Consortium. Incidence and risk factors for adalimumab and infliximab anti-drug
antibodies in rheumatoid arthritis: A European retrospective multicohort
analysis. Semin Arthritis Rheum. 2019 Jun;48(6):967-975. doi:
10.1016/j.semarthrit.2018.10.006. Epub 2018 Oct 12. PMID: 30420245.

Jensen PEH, Warnke C, Ingenhoven K, Piccoli L, Gasis M, Hermanrud C,
Fernandez-Rodriguez BM, Ryner M, Kramer D, Link J, Ramanujam R, Auer M, Buck D,
Grummel V, Bertotti E, Fissolo N, Oliver-Martos B, Nytrova P, Khalil M, Guger M,
Rathmaier S, Sievers-Stober C, Lindberg RLP, Hässler S, Bachelet D, Aktas O,
Donnellan N, Lawton A, Hemmer B, Havrdova EK, Kieseier B, Hartung HP, Comabella
M, Montalban X, Derfuss T, Sellebjerg F, Dönnes P, Pallardy M, Spindeldreher S,
Broët P, Deisenhammer F, Fogdell-Hahn A, Sorensen PS; ABIRISK Consortium.
Detection and kinetics of persistent neutralizing anti-interferon-beta
antibodies in patients with multiple sclerosis. Results from the ABIRISK
prospective cohort study. J Neuroimmunol. 2019 Jan 15;326:19-27. doi:
10.1016/j.jneuroim.2018.11.002. Epub 2018 Nov 7. PMID: 30447419.

Delsing L, Dönnes P, Sánchez J, Clausen M, Voulgaris D, Falk A, Herland A,
Brolén G, Zetterberg H, Hicks R, Synnergren J. Barrier Properties and
Transcriptome Expression in Human iPSC-Derived Models of the Blood-Brain
Barrier. Stem Cells. 2018 Dec;36(12):1816-1827. doi: 10.1002/stem.2908. Epub
2018 Nov 5. PMID: 30171748.

Bitoun S, Nocturne G, Ly B, Krzysiek R, Roques P, Pruvost A, Paoletti A,
Pascaud J, Dönnes P, Florence K, Gleizes A, Hincelin-Mery A, Allez M, Hacein-
Bey-Abina S, Mackay F, Pallardy M, Le Grand R, Mariette X. Methotrexate and BAFF
interaction prevents immunization against TNF inhibitors. Ann Rheum Dis. 2018
Oct;77(10):1463-1470. doi: 10.1136/annrheumdis-2018-213403. Epub 2018 Jun 23.
Erratum in: Ann Rheum Dis. 2021 May;80(5):e84. PMID: 29936438.

Adriani M, Nytrova P, Mbogning C, Hässler S, Medek K, Jensen PEH, Creeke P,
Warnke C, Ingenhoven K, Hemmer B, Sievers C, Lindberg Gasser RL, Fissolo N,
Deisenhammer F, Bocskei Z, Mikol V, Fogdell-Hahn A, Kubala Havrdova E, Broët P,
Dönnes P, Mauri C, Jury EC; ABIRISK Consortium. Monocyte NOTCH2 expression
predicts IFN-β immunogenicity in multiple sclerosis patients. JCI Insight. 2018
Jun 7;3(11):e99274. doi: 10.1172/jci.insight.99274. PMID: 29875313; PMCID:
PMC6124413.

Schubert B, Schärfe C, Dönnes P, Hopf T, Marks D, Kohlbacher O. Population-
specific design of de-immunized protein biotherapeutics. PLoS Comput Biol. 2018
Mar 2;14(3):e1005983. doi: 10.1371/journal.pcbi.1005983. PMID: 29499035; PMCID:
PMC5851651.

Link J, Ramanujam R, Auer M, Ryner M, Hässler S, Bachelet D, Mbogning C,
Warnke C, Buck D, Hyldgaard Jensen PE, Sievers C, Ingenhoven K, Fissolo N,
Lindberg R, Grummel V, Donnellan N, Comabella M, Montalban X, Kieseier B,
Soelberg Sørensen P, Hartung HP, Derfuss T, Lawton A, Sikkema D, Pallardy M,
Hemmer B, Deisenhammer F, Broët P, Dönnes P, Davidson J, Fogdell-Hahn A; ABIRISK
Consortium. Clinical practice of analysis of anti-drug antibodies against
interferon beta and natalizumab in multiple sclerosis patients in Europe: A
descriptive study of test results. PLoS One. 2017 Feb 7;12(2):e0170395. doi:
10.1371/journal.pone.0170395. PMID: 28170401; PMCID: PMC5295710.

Bachelet D, Hässler S, Mbogning C, Link J, Ryner M, Ramanujam R, Auer M,
Hyldgaard Jensen PE, Koch-Henriksen N, Warnke C, Ingenhoven K, Buck D, Grummel
V, Lawton A, Donnellan N, Hincelin-Mery A, Sikkema D, Pallardy M, Kieseier B,
Hemmer B, Hartung HP, Soelberg Sorensen P, Deisenhammer F, Dönnes P, Davidson J,
Fogdell-Hahn A, Broët P; ABIRISK Consortium. Occurrence of Anti-Drug Antibodies
against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative
Cohort Analysis. PLoS One. 2016 Nov 2;11(11):e0162752. doi:
10.1371/journal.pone.0162752. PMID: 27806057; PMCID: PMC5091903.